You are being redirected because this document is part of your ASTM Compass® subscription.
    This document is part of your ASTM Compass® subscription.

    Volume 23, Issue 2 (April 1978)

    Correlation of Antemortem and Postmortem Digoxin Levels

    (Received 25 July 1977; accepted 16 September 1977)

    Published Online: April

    CODEN: JFSOAD

      Format Pages Price  
    PDF 6 $25   ADD TO CART

    Cite this document

    X Add email address send
    X
      .RIS For RefWorks, EndNote, ProCite, Reference Manager, Zoteo, and many others.   .DOCX For Microsoft Word



    Abstract

    The dynamics of digoxin metabolism have been well studied since the introduction of sensitive radioimmunoassay procedures capable of detecting low biologic levels of this compound [1]. The value of monitoring digoxin therapy through serum levels has been widely accepted, and toxic effects are frequently observed when the serum level of adult individuals exceeds 2 ng/ml [2,3]. Beller et al [4] reported a twofold increase in mortality among hospitalized patients having digitalis toxicity.


    Author Information:

    Coe, JI
    Chief of pathology, Hennepin County Medical Center, Minneapolis, Minn.

    Vorpahl, TE
    Pathologist, St. Paul-Ramsey Hospital, St. Paul, Minn.


    Stock #: JFS10764J

    ISSN: 0022-1198

    DOI: 10.1520/JFS10764J

    ASTM International
    is a member of CrossRef.

    Author
    Title Correlation of Antemortem and Postmortem Digoxin Levels
    Symposium , 0000-00-00
    Committee E30